Supercritical Carbon Dioxide-Assisted Nebulization To Produce Fine Particles Of Stable Protein Formulations
Robert E. Sievers - American Association of Pharmaceutical Sciences Meeting, Arlington, Virginia, April, 2002
 1  2  3  4  5  6  7  8  9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32
next page

AKTIV-DRY™ Participants,
Advisors and Collaborators

  • John Carpenter, Ph.D., CU School of Pharmacy
  • Bob Sievers, Ph.D., CU Chemistry and Biochemistry Dept.
  • Eric Sievers, M.D., U Washington Medical School, and Fred Hutchinson Cancer Research Center
  • Michael Routh, Ph.D., CEO, Ionics Inc. Instrument Business Group
  • Misha Plam, Ph, D. former CEO of Sievers Instruments, Inc. (which was acquired by Ionics, Inc.)
  • Brian Quinn, M.B.A., Ph.D., investor and start-up executive
  • Ted Randolph, Ph.D., CU Chemical Engineering Dept.
  • Paul Brauer, M.S., CEO of Temco Instruments, Inc.
  • Others to be named
next page